J. Ogawa

Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.

S. Kume, Koji Matsumoto, M. Inoue, 2014, European journal of pharmacology.

Potent antidiabetic effects of rivoglitazone, a novel peroxisome proliferator-activated receptor-gamma agonist, in obese diabetic rodent models.

M. Yachi, J. Ohsumi, K. Araki, 2009, Journal of pharmacological sciences.

Contributions of hepatic gluconeogenesis suppression and compensative glycogenolysis on the glucose-lowering effect of CS-917, a fructose 1,6-bisphosphatase inhibitor, in non-obese type 2 diabetes Goto-Kakizaki rats.

T. Fujiwara, A. Okuno, Kanako Takahashi, 2011, Journal of pharmacological sciences.

Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats.

T. Fujiwara, A. Okuno, Jun Tanaka, 2009, European journal of pharmacology.

Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats.

T. Fujiwara, A. Okuno, Jun Tanaka, 2009, European journal of pharmacology.